Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa;Évolution des conditions d'initiation du traitement antirétroviral des patients infectés par le VIH en Afrique de l'Ouest

Medecine et Maladies Infectieuses

Volumn 40, Issue 8, 2010, Pages 449-455

  Bashi, J ^a   Balestre, E ^b   Messou, E ^c   Maiga, M ^d   Coffie, P A ^b,e   Zannou, D M ^a   Ba Gomis, O ^f   Traore, H A ^g   Eholie, S ^h   Minga, A ⁱ   Sow, P S ^j   Bissagnene, E ^h   Dabis, F ^b   Ekouevi, D K ^b,e  

^a CHNU   (Benin)

^b INSERM   (France)

^c ACONDA CePReF   (Côte d’Ivoire)

^d HÔPITAL GABRIEL TOURÉ   (Mali)

^e Programme PACCI   (Côte d’Ivoire)

^f Centre Integrée de Recherches Bioclinique d'Abidjan   (Côte d’Ivoire)

^g Hopital National du Point G   (Mali)

^h CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

ⁱ Centre Médical de Suivi de Donneurs de Sang CNTS PRIMO CI   (Côte d’Ivoire)

^j Centre Hospitalier Universitaire Dakar   (Senegal)

more..

Author keywords

Afrique de l'Ouest; Antir troviral; Antiretroviral therapy; HIV; VIH; West Africa

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE PLUS INDINAVIR PLUS STAVUDINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; UNCLASSIFIED DRUG;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; SEX DIFFERENCE; TREATMENT DURATION; TREND STUDY; MIDDLE AGED; TIME;

ADULT; AFRICA, WESTERN; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 77955924370     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.11.003     Document Type: Article

References (12)

1. WHO/UNAIDS/UNICEF. Vers un accès universel. Étendre les interventions prioritaires liées au VIH/sida dans le secteur de la santé. Rapport de situation 2008. 2008. Available from: Accessed 06 January 2009. http://www.who.int/hiv/pub/towards_universal_access_report_2008_fr.pdf.
2. UNAIDS. 2008 Report on the global AIDS Epidemic. 2008 [cited 200ç 08 November 2008]; Available from: Accessed 06 January 2009. http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp.
3. Braitstein P., Brinkhof M.W., Dabis F., Schechter M., Boulle A., Miotti P., et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006, 367(9513):817-824.
4. Stringer J.S., Zulu I., Levy J., Stringer E.M., Mwango A., Chi B.H., et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. J Am Med Assoc 2006, 296(7):782-793.
5. Calmy A., Pinoges L., Szumilin E., Zachariah R., Ford N., Ferradini L. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 2006, 20(8):1163-1169.
6. OMS et ONUSIDA. Élargissement de l'accès au traitement antirétroviral dans le monde: rapport sur l'initiative « 3 millions d'ici 2005 » et au-delà. Genève, mars 2006. Organisation mondiale de la Santé, 2006. Available from: Accessed 06 January 2009. http://www.who.int/hiv/progreport2006_fr.pdf.
7. OMS, ONUSIDA et UNICEF. Vers un accès universel: étendre les interventions prioritaires liées au VIH/sida dans le secteur de la santé. Rapport de situation, avril 2007. Genève, Organisation mondiale de la Santé. 2007. Available from: Accessed 06 January 2009. http://www.who.int/mediacentre/news/releases/2007/.
8. Gilks C.F., Crowley S., Ekpini R., Gove S., Perriens J., Souteyrand Y., et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006, 368(9534):505-510.
9. Keiser O., Anastos K., Schechter M., Balestre E., Myer L., Boulle A., et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 2008, 13(7):870-879.
10. Braitstein P., Boulle A., Nash D., Brinkhof M.W., Dabis F., Laurent C., et al. Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration. J Womens Health 2008, 17(1):47-55.
11. Tonwe-Gold B, Ekouevi DK, Amani-Bosse C, Toure S, Kone M, Becquet R, et al. Implementing family-focused HIV care and treatment: The first two years' experience of the MTCT-Plus program in Abidjan, Cote d'Ivoire. Trop Med Int Health 2009;14(2):204-212.
12. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006. Available from: Accessed 06 January 2009. http://www.who.int/hiv/pub/guidelines/pmtct/en/index.html.